“…Considering the absence of a specific tool for assessing OHs in PD patients, most authors opted to interview patients using semi-structured questionnaires or non-specific questions related to the presence of phantosmia [ 16 , 18 , 19 , 25 , 27 , 28 , 29 , 32 , 33 , 35 , 42 , 43 ]. Other authors assessed phantosmia in PD patients using structured questionnaires or interviews, including the Neuropsychiatric Inventory (NPI), the Schedule for Assessment of Positive Symptoms (SAPS), the Enhanced Scale for Assessment of Positive Symptoms in Parkinson’s Disease (eSAPS-PD), the MDS-UPDRS hallucinations and psychosis item, the Psycho-Sensory hAllucinations Scale (PSAS), the Psychosis and Hallucinations Questionnaire (PsycH-Q), and the University of Miami Parkinson’s disease Hallucinations Questionnaire (UM-PDHQ) [ 17 , 20 , 21 , 22 , 23 , 24 , 26 , 30 , 31 , 34 , 36 , 37 , 38 , 39 , 40 , 41 , 44 ]. However, the available data in the literature did not identify the most appropriate tool to assess the presence of phantosmia in PD patients.…”